SCHEMBL23770560

SCHEMBL23770560

OC(O)(O)c1ccccc1-c1nc(NSc2cccc(N3CCNCC3)n2)ccc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 2/20 0.40
ADRB2 P07550 2/20 0.40
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HTR3E A5X5Y0 2/20 0.34
HTR3B O95264 2/20 0.34
HTR3A P46098 2/20 0.34
HTR3D Q70Z44 2/20 0.34
HTR3C Q8WXA8 2/20 0.34
EPHX2 P34913 1/20 0.34
NCF1 P14598 1/20 0.33
HTR2C P28335 3/20 0.33
KARS1 Q15046 1/20 0.33
PRMT5 O14744 1/20 0.33
CYP3A4 P08684 2/20 0.32
HSD17B10 Q99714 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
CHEK1 O14757 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770663 0.88 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770628 0.86 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770606 0.85 ADRB2 (0.43) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770453 0.85 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770444 0.82 ADRB2 (0.42) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770770 0.81 ADRB2 (0.38) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770632 0.81 ADRB2 (0.42) CYP1A2CYP2C9CYP2C19ADRB2ALDH1A1
SCHEMBL23770433 0.79 PDE10A (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL23770664 0.79 NPY5R (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL23770859 0.78 CYP1A2 (0.44) CYP1A2CYP2C19ALDH1A1KDM4EHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed